Milan, Italy · Founded 2014 · Privately Held (backing)
Developer of an innovative medical technology designed to find new tissue regeneration methods. KLISBio is based in Milan, Italy and was founded in 2014. Its last reported valuation was $34.9 million in Dec 2022. It has raised $27.3 million.
Last reported valuation
$34.9M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
—
Cap table — not yet on record
KLISBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of KLISBio with a free account
·The complete investor list: 15 names
·Watch KLISBio: the Monday email on marks, rounds and moves
